BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18475105)

  • 1. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?
    Kaufman DA
    Curr Opin Pediatr; 2008 Jun; 20(3):332-40. PubMed ID: 18475105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to prevent invasive candidal infection in extremely preterm infants.
    Kaufman DA; Manzoni P
    Clin Perinatol; 2010 Sep; 37(3):611-28. PubMed ID: 20813274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
    Kaufman DA; Morris A; Gurka MJ; Kapik B; Hetherington S
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S87-90. PubMed ID: 24709470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
    Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
    Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants.
    Parikh TB; Nanavati RN; Patankar CV; Rao S; Bisure K; Udani RH; Mehta P
    Indian Pediatr; 2007 Nov; 44(11):830-7. PubMed ID: 18057479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.
    Manzoni P; Stolfi I; Pugni L; Decembrino L; Magnani C; Vetrano G; Tridapalli E; Corona G; Giovannozzi C; Farina D; Arisio R; Merletti F; Maule M; Mosca F; Pedicino R; Stronati M; Mostert M; Gomirato G; ;
    N Engl J Med; 2007 Jun; 356(24):2483-95. PubMed ID: 17568029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.
    Kaufman DA
    Early Hum Dev; 2012 May; 88 Suppl 2():S45-9. PubMed ID: 22633513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
    Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
    Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenging issues in neonatal candidiasis.
    Kaufman DA
    Curr Med Res Opin; 2010 Jul; 26(7):1769-78. PubMed ID: 20513206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Donowitz LG
    N Engl J Med; 2001 Dec; 345(23):1660-6. PubMed ID: 11759644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure.
    Weitkamp JH; Ozdas A; LaFleur B; Potts AL
    J Perinatol; 2008 Jun; 28(6):405-11. PubMed ID: 18185518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
    Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
    J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of invasive fungal infection in very low birthweight infants.
    Brecht M; Clerihew L; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F65-9. PubMed ID: 18838467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.
    Healy CM; Baker CJ; Zaccaria E; Campbell JR
    J Pediatr; 2005 Aug; 147(2):166-71. PubMed ID: 16126043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of fluconazole in neonatal intensive care units.
    Manzoni P; Mostert M; Jacqz-Aigrain E; Farina D
    Arch Dis Child; 2009 Dec; 94(12):983-7. PubMed ID: 19723639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
    Bertini G; Perugi S; Dani C; Filippi L; Pratesi S; Rubaltelli FF
    J Pediatr; 2005 Aug; 147(2):162-5. PubMed ID: 16126042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.